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This Month in the Journal
This month in the Journal, BenjaminNeale and Pak Sham
present their views on gene-based association studies, in
which all common variation within a candidate gene is
considered jointly. They advocate a movement toward
this type of approach for association studies of complex
disease, because it captures all potential risk-conferring
variation and thus can make a negative result moremean-
ingful because it is subject only to the power of the study.
Gene-based approaches take into account local allele
frequencies and linkage-disequilibrium structure and
thereby avoid complications due to population differ-
ences. This will allow more meaningful interpretation of
the results of replication studies performed in different
study populations. Although this approach is not fea-
sible for all genes at the present time, because of a lack
of knowledge of complete variation within every gene,
Neale and Sham feel that gene-based approaches are a
wise choice when attempting to replicate previous as-
sociations and that they will be increasingly useful as
additional gene variation is mapped.
Trisomy Recurrence, by Warburton et al. (p. 376)
Few studies have provided good estimates of recurrence
risks for trisomy. To look at this more thoroughly, War-
burton et al. collected data, from two sources, on 12,800
prenatal diagnoses for women with a history of a pre-
vious numerical-chromosome abnormality. The basic
question they asked was: Were these women more likely
to have either a trisomy of the same chromosome (homo-
trisomy) or a trisomy of a different chromosome (hetero-
trisomy) in a subsequent pregnancy? Their results con-
ﬁrm a previous ﬁnding that women who have trisomy
21 before age 30 years are at a signiﬁcantly increased
risk of having a second pregnancy with trisomy 21, but
Warburton et al. also found an increased risk in women
over age 30 years. One way to explain this recurrence is
through gonadal trisomy 21 mosaicism, a possibility that
is supported by other data. Things are not quite that sim-
ple, however, because there is also an increased risk of
heterotrisomy subsequent to a trisomic pregnancy. This
cannot be explained by gonadal mosaicism but, rather,
suggests variation in risk of meiotic nondisjunction be-
tween women.
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Genomewide Linkage Scan for Myopia, by Stambolian
et al. (p. 448)
Despite the fact that nearsightedness is obviously a very
common condition with a genetic component, the under-
lying defects are unknown. Although many might not
consider myopia to be an urgent problem, it actually
increases the risk of more-severe eye conditions, includ-
ing glaucoma and cataracts, so it is important from a
public health standpoint. Stambolian et al. present the
ﬁrst genome scan for common myopia in a sample of
Ashkenazi Jewish families. This relatively genetically iso-
lated study population was chosen to reduce heteroge-
neity in the sample, because it is likely that several genes
play a role in the development of myopia. In an effort
to further reduce heterogeneity and bias in the study,
myopia was treated as a binary—rather than a quanti-
tative—trait. Perhaps surprising for a common trait with
a large environmental component, the authors report a
strongly suggestive linkage to chromosome 22q12. Al-
though family-based association tests did not show an
obvious genetic association with this region, the fairly
wide spacing of markers at this stage of the study makes
it difﬁcult to draw conclusions from that result, so ﬁne
mapping of the region is under way.
Identiﬁcation of BBS3, by Chiang et al. (p. 475)
Bardet-Biedl syndrome (BBS) is a genetically heteroge-
neous disorder, the cardinal features of which include
obesity, mental retardation, polydactyly, and pigmentary
retinopathy. Eight loci have been mapped so far, and
some of the BBS genes have been identiﬁed through po-
sitional cloning and/or sequence comparisons with other
BBS genes. However, the rarity of BBS3-linked families
has precluded reﬁnement of this locus. On the basis of
the fact that some of the known BBS genes are involved
in cilia function, Mykytyn et al. (2004 [see reference in
Chiang et al.]) BLASTed BBS sequences against the ge-
nomes of a variety of organisms and found that, in gen-
eral, there were sequences homologous to the BBS genes
only in the ciliated organisms. Chiang et al. exploit this
fact to identify the BBS3 gene bioinformatically. They
looked for a set of candidate genes that had homologs
in ciliated organisms but not in unciliated organisms.
None of the resultant 114 genes mapped to the BBS3
interval, but one of them corresponded to the recently
identiﬁed BBS5, providing support for the general strat-
egy. From there, the authors looked for genes that were
in common between humans and ciliated organisms and
that localized to the BBS3 interval. This led them to
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identify ARL6 as BBS3. Affected individuals in the
kindred used to map BBS3 carry a homozygous trun-
cating mutation in this gene. ARL6 is a member of the
RAS superfamily of proteins, which have diverse func-
tions. Its precise role is unknown, but, on the basis of
current knowledge of the other BBS and ARL proteins,
Chiang et al. speculate it may be involved in intracellular
transport.
Prenatal Molecular Karyotype Using Microarrays, by
Larrabee et al. (p. 485)
Prenatal cytogenetic diagnosis by use of amniotic ﬂuid
(AF) samples takes at least a week, because viable amnio-
cytes must be cultured to gain sufﬁcient numbers for
metaphase analysis. Once the amniocytes have been re-
moved from a sample, some of the AF supernatant can
be used for the analysis of cellfree proteins, but the rest
of it is generally discarded. Larrabee et al. show that
this discarded fraction can actually be useful for prenatal
diagnosis of whole-chromosome aneuploidy because it
serves as a source of cellfree fetal DNA that can be an-
alyzed by comparative genomic hybridization microar-
rays. In this study, the number of each sex chromosome
and chromosome 21 could be determined accurately
through comparisons with euploid reference samples. A
number of samples lacked sufﬁcient amounts of cellfree
fetal DNA or did not hybridize well to the array, so this
technique is not ready for routine use. However, this
could turn out to be a more rapid, more comprehensive
way to look at prenatal samples in conjunction with
standard karyotyping.
PTPN22 R620W Is Associated with Human SLE, by
Kyogoku et al. (p. 504)
You may recall that two recent articles reported an as-
sociation of PTPN22 R620W with autoimmune disease,
one with rheumatoid arthritis (Begovich et al. 2004 [see
references in Kyogoku et al.]) and one with type I dia-
betes (Bottini et al. 2004); for a refresher, see lastmonth’s
installment of “This Month in the Journal.” With the
ﬁnding that PTPN22 R620W is associated with systemic
lupus erythematosus (SLE), Kyogoku et al. now provide
further evidence that PTPN22 is an autoimmunity gene.
In three independent cohorts of whites, this missense
change was associated with a dose-dependent increase in
risk of SLE. PTPN22 is a protein tyrosine phosphatase
that regulates T-cell signaling. Perhaps it is not surpris-
ing, therefore, that Ptpn22 knockout mice exhibit dys-
regulation of the effector/memory T-cell segment (Hase-
gawa et al. 2004). The authors propose that defects in
the regulation of T-cell signaling in carriers of R620W
facilitate the generation of the autoantibodies that are
characteristic of these autoimmune disorders.
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